TCG Crossover
Funding rounds backed by TCG Crossover.
- Funding disclosed in full
- $50M
- Median round
- $50M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Accro Bioscience Develops novel therapeutics for immune mediated diseases | $50MSeries C | BiotechUnited States |